Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling, Phase III
Updated: 3/19/2016
Clinical Research Facility
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling, Phase III
Updated: 3/19/2016
Clinical Research Facility
mi
from
New Bern, NC
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling, Phase III
Updated: 3/19/2016
Clinical Research Facility
mi
from
New London, CT
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling, Phase III
Updated: 3/19/2016
Clinical Research Facility
mi
from
Newburgh, IN
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling, Phase III
Updated: 3/19/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling, Phase III
Updated: 3/19/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling, Phase III
Updated: 3/19/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling, Phase III
Updated: 3/19/2016
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Neptune, NJ
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Wichita, KS
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dolphin Medical Research
mi
from
Doral, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Professionals, LLC - Olde Cabin Rd
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Charm City Research Group
mi
from
Towson, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Oncology Inc-Pali Momi
mi
from
'Aiea, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Dell Seton Medical Center at The University of Texas
mi
from
Austin, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Our Lady of the Lake Physicians Group - Medical Oncology
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
McLaren Cancer Institute-Bay City
mi
from
Bay City, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Mills-Peninsula Medical Center
mi
from
Burlingame, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Caro Cancer Center
mi
from
Caro, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Beaumont Hospital-Dearborn
mi
from
Dearborn, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Care Specialists of Illinois - Decatur
mi
from
Decatur, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Trinity Regional Medical Center
mi
from
Fort Dodge, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Palo Alto Medical Foundation-Fremont
mi
from
Fremont, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Central Care Cancer Center - Garden City
mi
from
Garden City, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Tidelands Georgetown Memorial Hospital
mi
from
Georgetown, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Central Care Cancer Center - Great Bend
mi
from
Great Bend, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Nevada Cancer Specialists-Saint Rose
mi
from
Henderson, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Cancer Care Inc-POB II
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwell Health- Center for Advanced Medicine
mi
from
Lake Success, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
University Cancer Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Hope Cancer Clinic
mi
from
Livonia, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph London
mi
from
London, KY
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Centra Lynchburg Hematology Oncology Clinic
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Monticello Cancer Center
mi
from
Monticello, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Fox Valley Hematology and Oncology SC-New London
mi
from
New London, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Chancellor Center for Oncology
mi
from
Newburgh, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Ontario
mi
from
Ontario, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Hope Cancer Care of Nevada-Pahrump
mi
from
Pahrump, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
McLaren Cancer Institute-Northern Michigan
mi
from
Petoskey, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Lake Huron Medical Center
mi
from
Port Huron, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Presbyterian Rust Medical Center/Jorgensen Cancer Center
mi
from
Rio Rancho, NM
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Rochester Hills
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser San Rafael-Gallinas
mi
from
San Rafael, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
HSHS Saint Nicholas Hospital
mi
from
Sheboygan, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Marshfield Clinic Stevens Point Center
mi
from
Stevens Point, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Ascension Saint Michael's Hospital
mi
from
Stevens Point, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Macomb Hematology Oncology PC
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Bhadresh Nayak MD PC-Warren
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
UPMC Susquehanna
mi
from
Williamsport, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Abington Memorial Hospital-Asplundh Cancer Pavilion
mi
from
Willow Grove, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Ann Arbor
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Genesis Healthcare System Cancer Care Center
mi
from
Zanesville, OH
Click here to add this to my saved trials
Genetic Disease Clinical Trial
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
Status: Enrolling, Phase
Updated: 12/31/1969
Pacific Northwest National Laboratory
mi
from
Richland, WA
Click here to add this to my saved trials
Hodgkin's Lymphoma Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087)
Status: Enrolling, Phase II
Updated: 3/3/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Hodgkin's Lymphoma Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087)
Status: Enrolling, Phase II
Updated: 3/3/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Hermann Hospital, Texas Medical Center - Clinical Research Unit (CRU)
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Arkansas Children's Hospital Research Pharmacy
mi
from
Little Rock, AR
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Commonwealth University Clinical Research Services Unit
mi
from
Richmond, VA
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Barnes-Jewish Hospital Department of Pharmacy
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hypophosphatasia Clinical Trial
Expanded Access Program for Asfotase Alfa Treatment for Patients With Infantile- or Juvenile-onset Hypophosphatasia (HPP)
Status: Enrolling, Phase
Updated: 12/31/1969
Hôpital Bicêtre
mi
from
Le Kremlin-Bicêtre,
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Chesterfield, MI
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Corona, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Macon, GA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Miramar, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling, Phase I, II
Updated: 2/4/2016
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling, Phase I, II
Updated: 2/4/2016
Clinical Research Facility
mi
from
Haughton, LA
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling, Phase I, II
Updated: 2/4/2016
Clinical Research Facility
mi
from
Lebanon, TN
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Status: Enrolling, Phase II
Updated: 2/13/2018
University of Alabama, Children's of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Sleepcare Clinical Research Institute
mi
from
Stockbridge, GA
Click here to add this to my saved trials
RLS Clinical Trial
An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Status: Enrolling, Phase IV
Updated: 12/31/1969
Pacific Research Network
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Chronic Total Occlusion of Coronary Artery Clinical Trial
A Prospective, Multi-Center, Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in Facilitating Crossing Chronic Total Occlusion (CTO) Coronary Lesions
Status: Enrolling
Updated: 4/3/2017
SPZOZ University Hospital in Krakow
mi
from
Krakow,
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Brooke Army Medical Center (Geneva Foundation)
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Citrus Valley Gastroenterology
mi
from
Glendora, CA
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Loma Linda Veterans Association for Research & Education
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Centex Studies - McAllen
mi
from
McAllen, TX
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Bruce W. Carter, Miami VA Medical Center
mi
from
Miami, FL
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
CHI Research Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Hahnemann University Hospital/Drexel University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Minnesota Gastroenterology, P.A.
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Huron Gastroenterology Associates
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Pali Momi Medical Center
mi
from
'Aiea, HI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
The Cancer Center of Hawaii-Pali Momi
mi
from
'Aiea, HI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Saint Joseph Mercy Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Aurora Cancer Care-Southern Lakes VLCC
mi
from
Burlington, WI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Saint Joseph Mercy Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
University of Cincinnati/Barrett Cancer Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Newland Medical Associates-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials